scispace - formally typeset
L

Luis Padilla-Noriega

Researcher at National Autonomous University of Mexico

Publications -  29
Citations -  664

Luis Padilla-Noriega is an academic researcher from National Autonomous University of Mexico. The author has contributed to research in topics: Rotavirus & Serotype. The author has an hindex of 14, co-authored 28 publications receiving 637 citations. Previous affiliations of Luis Padilla-Noriega include Universidad Autónoma de Nuevo León & Stanford University.

Papers
More filters
Journal ArticleDOI

Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4.

TL;DR: It is concluded that specific neutralization epitopes on each surface protein are capable of mediating protection against one or several rotavirus serotypes.
Journal ArticleDOI

Diversity of rotavirus serotypes in Mexican infants with gastroenteritis.

TL;DR: Stool specimens from infants with rotavirus gastroenteritis hospitalized in two Mexican cities were examined by serotype- and subgroup-specific enzyme immunoassays and indicate that heterotypic neutralizing antibody responses occur frequently following infection with serotype 4 rotaviruses.
Journal ArticleDOI

Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies.

TL;DR: At least one of the NMAbs described here recognizes an epitope unrelated to these previously identified epitopes, since it neutralized both KU and its variants.
Journal ArticleDOI

Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3.

TL;DR: Cross-neutralization assays showed that Wa VP4 has at least one large neutralization domain on its larger trypsin cleavage product, VP5*, consisting of several operationally related epitopes.
Journal ArticleDOI

Rotavirus protein NSP3 shuts off host cell protein synthesis.

TL;DR: A recombinant vaccinia virus encoding rotavirus protein NSP3 driven by an internal ribosome entry site (IRES) from the encephalomyocarditis virus was able to abate protein synthesis in BSC1 cells by 25-fold, with as much as 30% of the remaining protein synthesis being NSP 3.